Related Experiment Videos
E-cadherin gene mutations provide clues to diffuse type gastric carcinomas
K F Becker1, M J Atkinson, U Reich
1GSF-Forschungzentrum für Umwelt und Gesundheit, Institut für Pathologie, Oberschleissheim, Germany.
Cancer Research
|July 15, 1994
Summary
E-cadherin gene mutations are linked to diffusely growing gastric carcinomas, suggesting its role as a tumor suppressor. These findings highlight genetic alterations in gastric cancer development.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- E-cadherin is crucial for epithelial tissue integrity.
- Diffusely growing gastric carcinomas exhibit reduced cell-to-cell adhesion.
- E-cadherin gene mutations were hypothesized to cause this scattered phenotype.
Purpose of the Study:
- To investigate E-cadherin gene mutations in various gastric carcinoma types.
- To determine the role of E-cadherin alterations in diffuse gastric cancer development.
Main Methods:
- Analysis of E-cadherin at DNA, RNA, and protein levels in 53 gastric carcinomas.
- Reverse transcription polymerase chain reaction (RT-PCR) and direct sequencing of E-cadherin cDNA.
- Immunohistochemistry and allelic status analysis.
Main Results:
- E-cadherin mutations found in 50% of diffuse gastric carcinomas and 14% of mixed types.
- Exon 8 or 9 skipping and deletions identified, including splice site and non-splice site mutations.
- E-cadherin expression observed in tumors and metastases despite mutations, with loss of heterozygosity in one case.
Conclusions:
- E-cadherin gene mutations contribute to the development of diffusely growing gastric carcinomas.
- Findings support the hypothesis of E-cadherin as a tumor/metastasis suppressor gene.
- Specific mutations impact calcium binding domains and cell adhesion in gastric cancer.